Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Endothelial dysfunction: molecular mechanisms and clinical implications
2024 Standout
Works of Jielai Xia being referenced
Longterm Exercise-Derived Exosomal miR-342-5p
2019
EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jielai Xia | 126 | 471 | 441 | 426 | 80 | 1.5k | |
| Ping Feng | 56 | 409 | 199 | 319 | 110 | 2.0k | |
| Ståle Nygård | 92 | 397 | 209 | 354 | 81 | 2.2k | |
| J.P. Daurès | 35 | 278 | 226 | 315 | 72 | 2.2k | |
| Hsiao‐Hui Tsou | 260 | 367 | 270 | 168 | 78 | 1.7k | |
| Nicole S. Erler | 68 | 480 | 171 | 366 | 83 | 1.6k | |
| Bo Jin | 28 | 258 | 116 | 443 | 90 | 2.0k | |
| Irene M. Shui | 65 | 578 | 76 | 197 | 65 | 2.1k | |
| Michael Hagmann | 26 | 495 | 283 | 238 | 91 | 1.7k | |
| Eric Druyts | 38 | 516 | 209 | 192 | 81 | 1.9k | |
| Ken Liu | 14 | 668 | 701 | 505 | 117 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...